PLURISTEM THERAPEUTICS INC (PSTI) Stock Analyst Earnings Estimates
NASDAQ:PSTI - Nasdaq - US72940R3003 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50K | 50K | 20K -60.00% | -100.00% | 32.963M | 57.825M 75.43% | 99.452M 71.99% | 174.464M 75.43% | ||
| EBITDA YoY % growth | -31.71M -22.72% | -33.57M -5.87% | -27.91M 16.86% | N/A 286.28% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -33.73M -20.38% | -35.53M -5.34% | -29.48M 17.03% | -44.418M 271.71% | -42.33M -183.62% | -46.532M -9.93% | -3.389M 92.72% | -4.698M -38.62% | -6.642M -41.39% | |
| Operating Margin | -67,460.00% | -71,060.00% | -147,400.00% | N/A | N/A | -141.17% | -5.86% | -4.72% | -3.81% | |
| EPS YoY % growth | -2.60 18.75% | -3.03 -16.54% | -1.60 47.19% | -1.69 -10.00% | -1.04 40.89% | -1.68 -61.76% | -0.05 96.97% | -0.06 -15.30% | -0.07 -17.60% |
| Q4 / 22 | Q1 / 23 | Q2 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.33 29.04% | -0.31 15.00% | -0.32 7.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.31 35.42% | -0.33 | 0.02 | 5.02% |
| Q2 2022 Q2Q % growth | -0.34 30.61% | -0.19 | -0.15 | -80.18% |
| Q1 2022 Q2Q % growth | -0.36 -9.09% | -0.37 | 0.01 | 1.96% |
| Q4 2021 Q2Q % growth | -0.46 -43.75% | -0.39 | -0.07 | -18.68% |
| Q3 2021 Q2Q % growth | -0.48 -14.29% | -0.42 | -0.06 | -14.78% |
| Q2 2021 Q2Q % growth | -0.49 -22.50% | -0.41 | -0.08 | -19.11% |
| Q1 2021 Q2Q % growth | -0.33 28.26% | -0.34 | 0.01 | 3.42% |
| Q4 2020 Q2Q % growth | -0.32 49.21% | -0.27 | -0.05 | -18.39% |
| Q3 2020 Q2Q % growth | -0.42 53.33% | -0.10 | -0.32 | -311.76% |
| Q2 2020 Q2Q % growth | -0.40 42.86% | -0.37 | -0.03 | -7.44% |
| Q1 2020 Q2Q % growth | -0.46 42.50% | -0.37 | -0.09 | -25.27% |
| Q4 2019 Q2Q % growth | -0.63 | -0.54 | -0.09 | -17.65% |
| Q3 2019 Q2Q % growth | -0.90 | -0.67 | -0.23 | -33.69% |
| Q2 2019 Q2Q % growth | -0.70 | -0.65 | -0.05 | -8.36% |
| Q1 2019 Q2Q % growth | -0.80 | -0.77 | -0.04 | -4.58% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | 20K -60.00% | 20K | % | |
| Q1 2019 Q2Q % growth | 675.75K | -675.75K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |